Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-17

Clinical Trial Update: Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Abobotulinum Toxin vs Neubotulinum Toxin for hemifacial spasm in Thai patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abobotulinum Toxin (abobotulinum toxin type A)
  • Neubotulinum Toxin

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Hemifacial Spasm | Phase 3 | Status: COMPLETED